FDA ‘Struggles’ Against Spiked Supplements, ‘Thorn’ In Industry’s Side
This article was originally published in The Tan Sheet
A “continual thorn in the side of responsible” supplement firm is illegally spiked products, industry champion Senator Hatch says. FDA, meanwhile, “struggles to provide effective deterrents” to rid the market of bad actors.
You may also be interested in...
FDA finds four weight loss products that contain potentially dangerous undeclared ingredients, including DMAA and sibutramine. The agency also continues to warn about bee pollen with undeclared ingredients.
FDA proposed “a pretty crazy” NDI notification draft guidance, says attorney Wes Siegner, because “they think everything is an NDI.” Other stakeholders acknowledge FDA wants tighter regulation of the industry, but say writing and imposing rules for supplement manufacturing is a two-way street.
NAD review of Goli claims, looking at weight loss, physical performance, sexual function and sales claims, recommended it modify advertising to avoid conveying implied product efficacy claims for Ashwagandha Gummies and modify or discontinue qualified physical performance claim about ingredient KSM-66.